Fontus Health Ltd
Registered name: FONTUS HEALTH LTD
Part of Fontus Group Holdings Limited groupFontus Health Ltd made £13.4m revenue and £2m profit in the year to 31 Mar 2025. read from filing text
Fontus Health Ltd’s revenue grew 31% to £13.4m in the year to 31 Mar 2025, with £2m profit and 20 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Walsall; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- Walsall, West Midlands
- Age
- 14 yrs · since 2012
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Mar 2024 | 31 Mar 2025 |
|---|---|---|
| Disclosure | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | ||
| Revenue (turnover) | £10.3m | £13.4m |
| Cost of sales | £5.7m | £7.2m |
| Gross profit | £4.6m | £6.3m |
| Operating profit | £760k | £2.5m |
| Profit before tax | £852k | £2.6m |
| Profit after tax | £627k | £2m |
| Profit (best available) | £627k | £2m |
| Staff costs | £1.3m | £1.4m |
| Employees (average) | 17 | 20 |
| Ratios | ||
| Profit margin | 6.1% | 14.7% |
| Gross margin | 45% | 46.6% |
| Revenue per employee | £606k | £672k |
| Profit per employee | £36.9k | £99k |
| Cash conversion | 244% | −110.4% |
| Growth (year on year) | ||
| Revenue growth | — | ▲30.5% |
| Profit growth | — | ▲215.8% |
| Headcount growth | — | ▲17.6% |
| Balance sheet — indirect signals, not revenue | ||
| Cash at bank | £2.8m | £5.3m |
| Net assets | £9.2m | £11.2m |
| Fixed assets | £351k | £285k |
| Current assets | £11.5m | £16.1m |
| Debtors | £1.1m | £1.5m |
| Deferred income | £1.1m | £3m |
| Cash from operations | £1.9m | −£2.8m |
| Source | FullAccounts · bulk data Nov 2025 | FullAccounts · bulk data Nov 2025 |
How the business works
- Profit margin
- 14.7%
- Profit ÷ revenue.
- Gross margin
- 46.6%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £672k
- Revenue ÷ average employees.
- Profit per employee
- £99k
- Profit ÷ average employees.
- Cash conversion
- −110.4%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 2.1%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 22.4%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 11.2%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲21%
- Now £11.2m
- Cash at bank
- ▲89%
- Now £5.3m
- Headcount
- ▲18%
- Now 20
- Deferred income
- ▲166%
- Now £3m
- Fixed assets
- ▼19%
- Now £285k
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Ownership chain
- Fontus Group Holdings Limitedultimate parent75–100%
- Fontus Health Ltdthis company
Bands show the share of ownership each company holds in the one below it.
Subsidiaries (1)
- Norfon Consulting LtdFigures not disclosed
Sister companies (2)
- Fontus Investments LtdFigures not disclosed
- Fontus Pharma LtdFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- MW Encap LimitedLondon · Manufacture of basic pharmaceutical products
- Revenue
- £12.8m
- Profit
- £2.8m
- Staff
- 96
- Manx Healthcare LimitedWarwick · Manufacture of basic pharmaceutical products
- Revenue
- £12.6m
- Profit
- £5.6m
- Staff
- 31
- Envigo RMS (UK) LimitedLoughborough · Manufacture of basic pharmaceutical products
- Revenue
- £11.4m
- Profit
- £209k
- Staff
- 145
- Cosmarida LimitedSheffield · Manufacture of basic pharmaceutical products
- Revenue
- £11.1m
- Profit
- £286k
- Staff
- 90
- Pharmapac (U.K.) LimitedBidston, Wirral · Manufacture of basic pharmaceutical products
- Revenue
- £10.8m
- Profit
- £94.7k
- Staff
- 142
- Milton-Lloyd LimitedManufacture of basic pharmaceutical products
- Revenue
- £16.9m
- Profit
- £218k
- Staff
- 19
Sources
Latest figures from FullAccounts for the year to 31 Mar 2025 (profit £2m), from the Companies House accounts bulk data published Nov 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.